Abstract
A decreased ability to degrade neutrophil extracellular traps (NETs) is seen in a subgroup of patients with systemic lupus erythematosus (SLE) and correlates with the presence of autoantibodies. Antiphospholipid syndrome (APS) can develop secondary to SLE or as a primary disease. In the current study we investigated the ability of sera from patients with APS to degrade NETs. The presence of antibodies against NETs and neutrophil remnants were also determined in the same patients.
Original language | English |
---|---|
Pages (from-to) | 66-70 |
Journal | Clinical and Experimental Rheumatology |
Volume | 32 |
Issue number | 1 |
Publication status | Published - 2014 |
Subject classification (UKÄ)
- Rheumatology and Autoimmunity